Anti-VP6 VHH : an experimental treatment for rotavirus A-associated disease
Species A Rotaviruses (RVA) remain a leading cause of mortality in children under 5 years of age. Current treatment options are limited. We assessed the efficacy of two VP6-specific llama-derived heavy chain antibody fragments (VHH) -2KD1 and 3B2- as an oral prophylactic and therapeutic treatment ag...
| Main Authors: | , , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | Inglés |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.12123/1046 http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0162351&type=printable https://doi.org/10.1371/journal.pone.0162351 |
Similar Items: Anti-VP6 VHH : an experimental treatment for rotavirus A-associated disease
- Prevención y tratamiento de Rotavirus A mediante nanoanticuerpos VHH anti-VP6
- Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference? = Hacia el control de la diarrea por rotavirus A: ¿podrían los nanoanticuerpos VHH marcar la diferencia?
- Llamas contra el rotavirus humano
- IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
- Discovery and molecular characterization of a group A rotavirus strain detected in an Argentinean vicuña (Vicugna vicugna)
- Llamas : diagnóstico eficaz del Rotavirus